Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fox

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Biological Chemistry|April 26, 2011
Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB)Kefei Yuan, Canhua Huang, John Fox, et al.
Learning Health Systems|August 25, 2020
Rapid translation of clinical guidelines into executable knowledge: A case study of COVID-19 and online demonstrationJohn Fox, Omar Khan, Hywel Curtis, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2006
Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studiesRichard L Sukovaty, Jean W Lee, John Fox, et al.
Current Pharmaceutical Design|April 26, 2016
The Multifaceted Roles of Molecular Dynamics Simulations in Drug DiscoveryStephen John Fox, Jianguo Li, Yaw Sing Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosisAnthony B Hodsman, David A Hanley, Mark P Ettinger, et al.
Journal of Managed Care & Specialty Pharmacy|January 12, 2019
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer PerspectiveMitchell Reitsma, John Fox, Pierre Vanden Borre, et al.
Drug Testing and Analysis|March 1, 2012
The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)Pierce Kavanagh, Daniel Angelov, John O'Brien, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2008
Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary diseaseSarah J Deacon, Emma E Vincent, Paul L Greenhaff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Roundtable--the changing oncology landscape: evolution or revolution?Roy Beveridge, John Fox, Susan A Higgins, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2008
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agentsMartti Vaara, John Fox, Günther Loidl, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|April 26, 2011
Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB)Kefei Yuan, Canhua Huang, John Fox, et al.
Learning Health Systems|August 25, 2020
Rapid translation of clinical guidelines into executable knowledge: A case study of COVID-19 and online demonstrationJohn Fox, Omar Khan, Hywel Curtis, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2006
Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studiesRichard L Sukovaty, Jean W Lee, John Fox, et al.
Current Pharmaceutical Design|April 26, 2016
The Multifaceted Roles of Molecular Dynamics Simulations in Drug DiscoveryStephen John Fox, Jianguo Li, Yaw Sing Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosisAnthony B Hodsman, David A Hanley, Mark P Ettinger, et al.
Journal of Managed Care & Specialty Pharmacy|January 12, 2019
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer PerspectiveMitchell Reitsma, John Fox, Pierre Vanden Borre, et al.
Drug Testing and Analysis|March 1, 2012
The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)Pierce Kavanagh, Daniel Angelov, John O'Brien, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2008
Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary diseaseSarah J Deacon, Emma E Vincent, Paul L Greenhaff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Roundtable--the changing oncology landscape: evolution or revolution?Roy Beveridge, John Fox, Susan A Higgins, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2008
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agentsMartti Vaara, John Fox, Günther Loidl, et al.
Pageof 16